Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : The *NEW* Frank Coluccio Technology Forum -- Ignore unavailable to you. Want to Upgrade?

To: Frank A. Coluccio who wrote (79)	6/7/2000 2:00:00 PM
From: Peter Sherman	Read Replies (1) \| Respond to of 46821

hi - found new thread by accident - formerly followed the guru of Bay Ridge - as a QCOM person, I hope to lurk and learn here - i hope I have a welcome - thanx............

To: Frank A. Coluccio who wrote (79)	6/7/2000 3:43:00 PM
From: Stephen L	Read Replies (1) \| Respond to of 46821

How about FTT-Desktop Avanex Introduces 'Wavelength to the Desktop' Application, Along With New PowerExpress Integrated Long-Haul Photonic Processor FREMONT, Calif., June 7 /PRNewswire/ -- Avanex Corporation (Nasdaq: AVNX), the leading provider of photonic processors for optical communications networks, today introduced its PowerExpress(TM) Integrated Long-Haul Processor and an innovative Adaptive Network Enterprise Application that delivers "Wavelength to the Desktop." Avanex President and CEO Walter Alessandrini announced the company's latest photonic processor innovations during a news conference at SUPERCOMM 2000, the telecommunications industry's premier trade show being held at the Georgia World Congress Center Atlanta through Thursday. Avanex is in Booth #8607. The Avanex Adaptive Network Enterprise Application features Avanex's PowerMux(TM) Wavelength Channel Processor to support voice, data, video, and wavelength services and distribution in an enterprise network. The application has been successfully demonstrated in a commercial-campus environment field trial in Hong Kong. "Avanex has developed an application using the PowerMux that holds great promise for enterprise networks," Walter Alessandrini said. "It allows the delivery of multiple services, which is a key issue for enterprise applications, and is ideally suited to a market that CIR (Communications Industries Researchers, Inc.) predicts will more than double to approximately $2.5 billion in the U.S. alone by 2004." In the Adaptive Network Enterprise Application, flexible wavelength routing and efficient bandwidth management provide minimum cost per wavelength and compatibility with any Metro application. Optical add-drop capability maximizes fiber utilization. The PowerMux's compact design enables extremely dense packaging and easy installation, and the low insertion loss inherent in the PowerMux's performance negates the need for optical amplifiers. Since it is format and bit-rate independent, the application can distribute any known service. Avanex's newest photonic processor, the PowerExpress, offers ultra-long- haul fiber optic transmission without costly electrical regeneration of the signal. Avanex is demonstrating the PowerExpress in a 3,000-kilometer configuration during SuperComm. The PowerExpress provides self-contained optical regeneration and optical reshaping for maximum distance with a minimum bit-error rate. The PowerExpress integrates Avanex's award-winning PowerShaper(TM) Dispersion Management Processor and mid-stage add/drop functionality along with optical regeneration capability. "The PowerExpress offers a level of integration required by next- generation optical networks," Alessandrini said. "It is another example of how Avanex combines its advanced optical technologies with its network architecture expertise to provide low-cost wavelengths in abundance." In the booth demonstration at SuperComm, the PowerExpress enables 50 GHz- spaced, high-channel-count DWDM transmission without electrical regeneration on a 3000-kilometer network. It provides full bit-rate and data format transparency, and supports multiple reconfigurable wavelength add-drop nodes, with no need of Raman amplification and no need of FEC and RZ coding. Avanex also is displaying its new PowerMux NxG(TM) at SuperComm. The PowerMux NxG, a next-generation of the company's highly acclaimed PowerMux photonic processor, applies a high level of integration resulting in a small footprint combined with Avanex's new holographic diffraction grating technology to deliver further reductions in cost per wavelength and high- volume manufacturing capability. About Avanex Avanex designs, manufactures and markets photonic processors for the communications industry. Avanex's photonic processors offer communications service providers and optical systems manufacturers greater levels of performance and miniaturization, reduced complexity and increased cost- effectiveness as compared to current alternatives. Avanex was incorporated in 1997 and is headquartered in Fremont, Calif. In addition to a development and manufacturing facility in Fremont, the company also maintains The Photonics Center(TM) in Richardson, Texas. To learn more about Avanex, visit its web site at: www.avanex.com . Forward-looking Statements This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act. Actual results could differ materially from those projected in the forward-looking statements. Forward-looking statements involve risks and uncertainties including, but not limited to, our inability to sufficiently anticipate market needs and develop products and product enhancements that achieve market acceptance. Avanex undertakes no obligation to publicly release the result of any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

To: Frank A. Coluccio who wrote (79)	6/7/2000 6:51:00 PM
From: Tarzan	Read Replies (1) \| Respond to of 46821

Have you ever heard of Celsion Corporation (CLN)? Paul Harvey talked about them on his program today. What do you think? This was the focus of his comments: Monday June 5, 10:25 am Eastern Time Company Press Release Massachusetts Institute of Technology Issues Press Release On Its Breast Cancer Treatment Technology, Exclusively Licensed to Celsion Corporation COLUMBIA, Md.--(BUSINESS WIRE)--June 5, 2000--Celsion Corporation (AMEX:CLN - news) announced today that Massachusetts Institute of Technology (MIT), located in Cambridge, MA, has issued a press release detailing the history and development of its breast cancer treatment technology, which is licensed exclusively to Celsion Corporation. The full release can be viewed at the MIT News Office web page, at web.mit.edu. The technology upon which the breast cancer treatment is based was initially developed ten years ago by Dr. Alan J. Fenn, senior staff member of the Advanced Electromagnetic Systems Group at Lincoln Laboratory, MIT. The technique utilizes microwave signals to heat and kill cancer cells in breast tissue. Its efficacy is based on the fact that cancer cells contain almost 80% water, while healthy cells contain less than 20% water. The microwave signal targets the heat at the cancerous cells, ablating (killing) them through superheating, while avoiding overheating the healthy tissue. Side effects appear to be limited to slight fever following the procedure. As of this spring, seven women have participated in an FDA-approved clinical study of the treatment; three other women will soon be treated. The next trial, (Phase II Clinicals), which could be completed within the year, will include 100 patients who will be treated for early-stage or advanced breast cancer. MIT has exclusively licensed the technology to Celsion Corporation, which underwrites the clinical trials required by the FDA. Spencer Volk, Celsion President and Chief Executive Officer of Celsion, stated, ``Celsion is proud to be the sponsor of such a critically important treatment technique in the fight against breast cancer. We will continue to fully support the clinical trial process until we can bring the treatment - with complete FDA approval - to the medical community and breast cancer patients at large.'' About Celsion: Celsion Corporation is a research and development company dedicated to commercializing medical treatment systems for cancer and other diseases using focused heat technology delivered by patented microwave technology. Celsion has research, license or commercialization agreements with leading institutions such as Duke University Medical Center, Massachusetts Institute of Technology, Harbor UCLA Medical Center, the University of California at San Francisco, Montefiore Medical Center, Memorial Sloan Kettering Cancer Center in New York and Duke University.